Galantamine hydrobromide
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151541This classification denotes an acetylcholinesterase inhibitor with the molecular formula C17H21NO3.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MJ4PTD2VVW, chemically known as 1,2,3,4,6,7,7a,11c-octahydro-9-methoxy-2-methyl-benzofuro(4,3,2-efg)(2)benzazocin-6-ol hbr but more generally known as galantamine hydrobromide, which bears US NIH Compound Identifier 121587. European Medicines Agency schedules Galantamine hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02301MIG. Most nations, for tariff and trade purposes, schedule galantamine hydrobromide under HS 29399900 and SITC 54149. As of Q4 2014, GALANTAMINE HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Galantamine hydrobromide bears US NLM identifiers UMLS ID C0949312 and NCI Concept Code C47546. SMILES: CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4C3C(CCC4OC)C1)O.BR.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.